# Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

> **NCT04220970** · — · RECRUITING · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 150 (estimated)

## Conditions studied

- Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

## Interventions

- **OTHER:** BIA-ALCL

## Key facts

- **NCT ID:** NCT04220970
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-06-07
- **Primary completion:** 2032-06-07
- **Final completion:** 2032-06-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04220970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04220970, "Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04220970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*